In this Quarterly Report on Form 10-Q, Adtalem Global Education Inc., together
with its subsidiaries, is collectively referred to as "Adtalem," "we," "our,"
"us," or similar references.

Discussions within the MD&A may contain forward-looking statements. See the
"Forward-Looking Statements" section for details about the uncertainties that
could cause our actual results to be materially different than those expressed
in our forward-looking statements.

Throughout this MD&A, we sometimes use information derived from the Consolidated
Financial Statements and the notes thereto but not presented in accordance with
U.S. generally accepted accounting principles ("GAAP"). Certain of these items
are considered "non-GAAP financial measurers" under the Securities and Exchange
Commission ("SEC") rules. See the "Non-GAAP Financial Measures and
Reconciliations" section for the reasons we use these non-GAAP financial
measures and the reconciliations to their most directly comparable GAAP
financial measures.

Certain items presented in tables may not sum due to rounding. Percentages
presented are calculated from the underlying numbers in thousands. Discussions
throughout this MD&A are based on continuing operations unless otherwise noted.
The MD&A should be read in conjunction with the Consolidated Financial
Statements and the notes thereto.

Available Information



Through its website, Adtalem offers its Annual Report on Form 10-K, Quarterly
Reports on Form 10-Q, and other reports filed with the SEC. Adtalem's website is
http://www.adtalem.com. Except as otherwise stated in these reports, the
information contained on our website or available by hyperlink from our website
is not incorporated into our Annual Report on Form 10-K, this Quarterly Report
on Form 10-Q, or other documents we file with, or furnish to, the SEC.

Segments

During the fourth quarter of fiscal year 2019, Adtalem renamed two of its segments: Professional Education was renamed Financial Services, and Technology and Business was renamed Business and Law.



                                       38

Table of Contents



As of September 30, 2019, Adtalem eliminated its Business and Law reportable
segment when Adtalem Education of Brazil ("Adtalem Brazil") was classified as
discontinued operations and assets held for sale. In addition to the potential
sale of Adtalem Brazil, during the second quarter of fiscal year 2019, Adtalem
divested DeVry University and Carrington College ("Carrington"). In accordance
with GAAP, we have classified the DeVry University, Carrington, and Adtalem
Brazil entities as "Held for Sale" and "Discontinued Operations" in all periods
presented as applicable. As a result, all financial results, disclosures, and
discussions of continuing operations in this Quarterly Report on Form 10-Q
exclude DeVry University, Carrington, and Adtalem Brazil operations, unless
otherwise noted. See Note 4 "Discontinued Operations and Assets Held for Sale"
to the Consolidated Financial Statements for additional discontinued operations
information.

We present two reportable segments as follows:



Medical and Healthcare - Offers degree and non-degree programs in the medical
and healthcare postsecondary education industry. This segment includes the
operations of Chamberlain University ("Chamberlain"), American University of the
Caribbean School of Medicine ("AUC"), Ross University School of Medicine
("RUSM"), and Ross University School of Veterinary Medicine ("RUSVM").

Financial Services - Offers test preparation, certifications, conferences,
seminars, memberships, and subscriptions to business professionals in the areas
of accounting, anti-money laundering, banking, and mortgage industries. This
segment includes the operations of the Association of Certified Anti-Money
Laundering Specialists ("ACAMS"), Becker Professional Education ("Becker"),
OnCourse Learning ("OCL"), and EduPristine.

"Home Office and Other" includes activity not allocated to a reportable segment.
Financial and descriptive information about Adtalem's reportable segments is
presented in Note 20 "Segment Information" to the Consolidated Financial
Statements.

Certain expenses previously allocated to Adtalem Brazil within our former
Business and Law segment during fiscal year 2019 have been reclassified to the
Home Office and Other segment based on discontinued operations reporting
guidance regarding allocation of corporate overhead. For fiscal year 2020, home
office costs to support the remaining businesses are being allocated to the
Medical and Healthcare and Financial Services segments.

Second Quarter Highlights

Financial and operational highlights for the second quarter of fiscal year 2020 include:

Adtalem revenue grew $12.2 million, or 4.8%, in the second quarter of fiscal

? year 2020 compared to the year-ago quarter, driven by increased revenue in both

the Medical and Healthcare and the Financial Services segments.

Net income from continuing operations attributable to Adtalem of $1.4 million

decreased $40.5 million, or 96.6%, in the second quarter of fiscal year 2020

compared to the year-ago quarter primarily driven by an insurance settlement

gain of $15.6 million recorded in the second quarter of fiscal year 2019, with

no comparable gain in the current year quarter, and an unrealized $28.0

? million loss recorded in the second quarter of fiscal year 2020 on the

deal-contingent foreign currency hedge arrangement entered into in connection

with the announced proposed sale of Adtalem Brazil to economically hedge the

Brazilian Real denominated purchase price through mitigation of the currency

exchange rate risk. The change in value in this hedge does not result in a

change in proceeds, net of the hedge settlement, from the amount originally

expected from the sale transaction.

Net income attributable to Adtalem decreased $11.8 million, or 68.1%, in the

second quarter of fiscal year 2020 compared to the year-ago quarter. Net income

? from continuing operations attributable to Adtalem excluding special items of

$30.9 million decreased $3.4 million, or 9.8%, in the second quarter of fiscal

year 2020 compared to the year-ago quarter.

For the November 2019 session, new and total student enrollment at Chamberlain

? increased 3.6% and 1.2%, respectively, compared to the same term last year.


   Chamberlain continues to invest in its programs, student services, and campus
   locations.


                                       39

  Table of Contents

   The acquisition of OCL in May 2019, contributed to revenue growth in the

Financial Services segment of 9.1% in the second quarter of fiscal year 2020

compared to the year-ago quarter. Revenue was negatively affected by $5.3

? million in the second quarter of fiscal year 2020 by the shift of revenue from

the largest annual ACAMS conference from the second quarter of fiscal year 2019

to the first quarter of fiscal year 2020. ACAMS memberships have increased to

more than 77,000 as of December 31, 2019.

Adtalem continued its eleventh share repurchase program by repurchasing a total

? of 1,755,160 shares of Adtalem's common stock at an average cost of $34.05 per

share during the second quarter of fiscal year 2020.

Results of Operations

The following table presents selected Consolidated Statements of Income data as a percentage of revenue for each of the periods indicated.




                                           Three Months Ended          Six Months Ended
                                              December 31,               December 31,
                                            2019         2018          2019        2018
Revenue                                       100.0 %     100.0 %       100.0 %     100.0 %
Cost of educational services                   47.8 %      46.5 %        49.0 %      46.8 %
Student services and administrative
expense                                        36.3 %      35.1 %        37.6 %      36.3 %
Restructuring expense                           0.7 %       1.4 %         1.6 %       8.8 %
Gain on sale of assets                          0.0 %       0.0 %       (0.9) %       0.0 %
Settlement gain                                 0.0 %     (6.1) %         0.0 %     (3.2) %
Total operating cost and expense               84.9 %      76.9 %        87.3 %      88.7 %
Operating income from continuing
operations                                     15.1 %      23.1 %        12.7 %      11.3 %
Net other expense                            (11.8) %     (2.0) %       (6.9) %     (1.8) %
Income from continuing operations
before income taxes                             3.3 %      21.2 %         5.8 %       9.5 %
Income tax provision                          (2.8) %     (4.7) %       (2.2) %     (1.9) %
Income from continuing operations               0.5 %      16.5 %         3.6 %       7.5 %
Income (loss) from discontinued
operations, net of tax                          1.5 %     (9.6) %         0.2 %     (5.9) %
Net income                                      2.0 %       6.9 %         3.8 %       1.6 %
Net loss (income) attributable to
redeemable noncontrolling interest              0.0 %     (0.1) %         0.0 %     (0.0) %
Net income attributable to Adtalem              2.1 %       6.8 %         3.8 %       1.6 %


Revenue

The following tables present revenue by segment detailing the changes from the year-ago periods (in thousands):




                                                     Three Months Ended December 31, 2019
                                         Medical and      Financial     Home Office
                                          Healthcare      Services       and Other      Consolidated
Fiscal year 2019 as reported             $    212,627    $    42,142   $       (808)   $      253,961
Organic growth                                  7,553        (4,269)             808            4,092
Effect of acquisitions                              -          8,119               -            8,119
Fiscal year 2020 as reported             $    220,180    $    45,992   $           -   $      266,172

Fiscal year 2020 % change:
Organic growth                                    3.6 %       (10.1) %            NM              1.6 %
Effect of acquisitions                              -           19.3 %            NM              3.2 %

Fiscal year 2020 % change as reported             3.6 %          9.1 %     

      NM              4.8 %




                                       40

  Table of Contents


                                                      Six Months Ended December 31, 2019
                                          Medical and     Financial     Home Office
                                          Healthcare      Services       and Other      Consolidated
Fiscal year 2019 as reported             $     414,727   $    77,788   $     (1,615)   $      490,900
Organic growth                                  12,940         (402)           1,615           14,153
Effect of acquisitions                               -        15,732               -           15,732
Fiscal year 2020 as reported             $     427,667   $    93,118   $           -   $      520,785

Fiscal year 2020 % change:
Organic growth                                     3.1 %       (0.5) %            NM              2.9 %
Effect of acquisitions                               -          20.2 %            NM              3.2 %

Fiscal year 2020 % change as reported              3.1 %        19.7 %            NM              6.1 %


Total consolidated revenue for the second quarter of fiscal year 2020 of $266.2
million increased 4.8%, or $12.2 million, compared to the year-ago quarter.
Total consolidated revenue for the first six months of fiscal year 2020 of
$520.8 million increased 6.1%, or $29.9 million, compared to the year-ago
period. Excluding the revenue added from OCL, which was acquired in the fourth
quarter of fiscal year 2019, revenue grew 1.6%, or $4.1 million, in the second
quarter and grew 2.9%, or $14.2 million, in the first six months of fiscal year
2020 compared to the year-ago periods.

Medical and Healthcare



Revenue in the Medical and Healthcare segment increased 3.6%, or $7.6 million,
to $220.2 million in the second quarter and increased 3.1%, or $12.9 million, to
$427.7 million in the first six months of fiscal year 2020 compared to the
year-ago periods. The increase in revenue in the second quarter and first six
months of fiscal year 2020 is driven primarily by a revenue increase at
Chamberlain primarily due to increasing total student enrollment and a revenue
increase at the medical and veterinary schools primarily due to increased
housing revenue at RUSM from its Barbados campus.

Chamberlain

Chamberlain Student Enrollment:




                                             Fiscal Year 2020
Term                               July 2019    Sept. 2019    Nov. 2019
New students                           2,396         5,595        2,711
% change from prior year               (5.0) %         2.9 %        3.6 %
Total students                        28,691        31,736       31,215
% change from prior year                 2.3 %         1.4 %        1.2 %

                                                                Fiscal Year 2019
Term                               July 2018    Sept. 2018    Nov. 2018    Jan. 2019    Mar. 2019    May 2019
New students                           2,523         5,435        2,617        4,759        2,726       3,997
% change from prior year                 1.0 %         9.5 %      (6.7) %        6.4 %      (3.7) %       2.6 %
Total students                        28,037        31,295       30,833       32,354       32,104      30,867
% change from prior year                 4.6 %         4.1 %        3.7 %        3.3 %        3.4 %       1.8 %


Chamberlain revenue increased 2.7%, or $3.2 million, to $125.5 million in the
second quarter and increased 2.6%, or $6.1 million, to $242.0 million in the
first six months of fiscal year 2020 compared to the year-ago periods, driven by
increases in total student enrollment in the July 2019, September 2019, and
November 2019 sessions. Chamberlain admitted its largest class of campus
students in September 2019.

Chamberlain currently operates 22 campuses in 15 states. Chamberlain's newest campus in San Antonio, Texas, began instruction in October 2019.



                                       41

  Table of Contents

Tuition Rates:

Tuition for the Bachelor of Science in Nursing ("BSN") onsite degree program is
$675 per credit hour. Tuition for the Registered Nurse to BSN ("RN-to-BSN")
online degree program is $590 per credit hour. Tuition for the online Master of
Science in Nursing ("MSN") degree program is $650 per credit hour. Tuition for
the Family Nurse Practitioner ("FNP") degree program is $665 per credit hour.
Tuition for the online Doctor of Nursing Practice ("DNP") degree program is $750
per credit hour. Tuition for the Master of Public Health ("MPH") degree program
is $550 per credit hour. Tuition for the online Master of Social Work ("MSW")
degree program, which began in September 2019, is $695 per credit hour. All of
these tuition rates are unchanged from the prior year. These tuition rates do
not include the cost of books, supplies, transportation, or living expenses.

Medical and Veterinary Schools

Medical and Veterinary Schools Student Enrollment:




                            Fiscal Year 2020
Term                           Sept. 2019
New students                             872
% change from prior year               (1.9) %
Total students                         5,608
% change from prior year               (4.7) %

                                        Fiscal Year 2019
Term                           Sept. 2018       Jan. 2019    May 2019
New students                             889          471         496
% change from prior year                 9.5 %      (8.5) %     (0.6) %
Total students                         5,887        5,548       5,220
% change from prior year                 2.5 %      (6.6) %     (6.0) %


The medical and veterinary schools' revenue increased 4.8%, or $4.3 million, to
$94.7 million in the second quarter and increased 3.8%, or $6.8 million, to
$185.7 million in the first six months of fiscal year 2020 compared to the
year-ago periods. The principal driver of the increases were higher housing
revenue at the new Barbados campus of RUSM. These increases were partially
offset by lower tuition revenue at AUC and RUSM driven by lower enrollment and
increased discounts and scholarships from listed tuition rates.

In the September 2019 semester, total student enrollment declined at AUC, RUSM,
and RUSVM, and new student enrollment increased at AUC and RUSVM and declined at
RUSM. The lower enrollment is the result of heightened competition. Management
is executing its plan to differentiate the medical and veterinary schools from
the competition, with a core goal of increasing international students,
increasing RUSM affiliations with historically black colleges and universities
("HBCU") and Hispanic-serving institutions ("HSI"), expanding AUC's medical
education program based in the U.K. in partnership with the University of
Central Lancashire ("UCLAN"), and improving the effectiveness of marketing
investments. Management believes the demand for medical and veterinary education
remains strong and can support management's longer-term expectations to grow new
enrollments in the low-single digit range; however, heightened competition may
continue to adversely affect the medical and veterinary schools' ability to
continue to attract qualified students to its programs resulting in lower
tuition revenue.

In September 2019, AUC opened its medical education program in the U.K. in
partnership with UCLAN. The program offers students a postgraduate diploma in
International Medical Sciences ("PGDip-IMS") from UCLAN, followed by their
Doctor of Medicine degree from AUC. Students will then be eligible to do
clinical rotations at AUC's clinical sites, which include hospitals in the U.S.,
the U.K., and Canada. This program is aimed at preparing students for the U.S.
Medical Licensing Examination ("USMLE").

In January 2019, RUSM moved its basic science instruction to a new location in
Barbados. The academic facility is located in Bridgetown and student housing is
located close to the academic facility in the parish of Christ Church and
includes amenities, student services, and convenient transportation to campus.

                                       42

  Table of Contents

Tuition Rates:

Effective for semesters beginning in September 2019, tuition rates for the

? beginning basic sciences and final clinical rotation portions of AUC's medical

program are $23,240 and $26,000, respectively, per semester. These tuition

rates represent a 3.5% increase over the prior academic year.

Effective for semesters beginning in September 2019, tuition rates for the

beginning basic sciences and Internal Medicine Foundations/final clinical

? portion of the programs at RUSM are $24,170 and $26,676, respectively, per

semester. These tuition rates represent a 4.0% increase over the prior academic

year.

For students who entered the RUSVM program in September 2018 or later, the

tuition rate for the pre-clinical (Semesters 1-7) and clinical curriculum

(Semesters 8-10) is $20,873 per semester effective September 2019. For students

? who entered RUSVM before September 2018, tuition rates for the pre-clinical and

clinical curriculum are $19,387 and $24,339, respectively, per semester

effective September 2019. The tuition rates effective September 2019 represent

a 2.8% increase over the prior academic year.

The respective tuition rates for AUC, RUSM, and RUSVM do not include the cost of transportation, living expenses, or health insurance.

Financial Services


Revenue in the Financial Services segment increased 9.1%, or $3.9 million, to
$46.0 million in the second quarter and increased 19.7%, or $15.3 million, to
$93.1 million in the first six months of fiscal year 2020 compared to the
year-ago periods. Excluding the revenue added from OCL, which was acquired in
the fourth quarter of fiscal year 2019, revenue declined 10.1%, or $4.3 million,
in the second quarter and declined 0.5%, or $0.4 million, in the first six
months of fiscal year 2020 compared to the year-ago periods. The decrease in
revenue in the second quarter of fiscal year 2020 was impacted by $5.3 million
due to the timing of the largest ACAMS conference of the year, which took place
in the first quarter of fiscal year 2020 compared to it taking place in the
second quarter of fiscal year 2019. The divestiture of Becker's courses for
healthcare students, which was completed in August 2019, also decreased revenue
by $1.5 million and $2.8 million in the second quarter and the first six months
of fiscal year 2020, respectively. These revenue decreases were partially offset
by growth in other ACAMS product sales. ACAMS memberships have increased to more
than 77,000 as of December 31, 2019, driven by strong domestic growth as well as
expansion in the Asia Pacific and European regions.

Cost of Educational Services



The largest component of cost of educational services is the cost of faculty and
staff who support educational operations. This expense category also includes
the costs of facilities, adjunct faculty, supplies, housing, bookstore, other
educational materials, student education-related support activities, and the
provision for bad debts. The following tables present cost of educational
services by segment detailing the changes from the year-ago periods (in
thousands):


                                                Three Months Ended December 31, 2019
                                   Medical and      Financial      Home Office
                                    Healthcare      Services        and Other       Consolidated
Fiscal year 2019 as reported       $    109,142    $     9,084    $       (149)    $      118,077
Cost increase (reduction)                 8,845        (3,140)              716             6,421
Effect of acquisitions                        -          2,760                -             2,760
Fiscal year 2020 as reported       $    117,987    $     8,704    $         567    $      127,258

Fiscal year 2020 % change:
Cost increase (reduction)                   8.1 %       (34.6) %             NM               5.4 %
Effect of acquisitions                        -           30.4 %             NM               2.3 %
Fiscal year 2020 % change as
reported                                    8.1 %        (4.2) %             NM               7.8 %




                                       43

  Table of Contents


                                                 Six Months Ended December 31, 2019
                                   Medical and      Financial      Home Office
                                    Healthcare      Services        and Other       Consolidated
Fiscal year 2019 as reported       $    214,782    $    15,028    $       (199)    $      229,611
Cost increase (reduction)                19,944           (44)            1,382            21,282
Effect of acquisitions                        -          4,399                -             4,399
Fiscal year 2020 as reported       $    234,726    $    19,383    $       1,183    $      255,292

Fiscal year 2020 % change:
Cost increase (reduction)                   9.3 %        (0.3) %             NM               9.3 %
Effect of acquisitions                        -           29.3 %             NM               1.9 %
Fiscal year 2020 % change as
reported                                    9.3 %         29.0 %             NM              11.2 %


Cost of educational services increased 7.8%, or $9.2 million, to $127.3 million
in the second quarter and increased 11.2%, or $25.7 million, to $255.3 million
in the first six months of fiscal year 2020 compared to the year-ago periods.
Excluding the costs added with the acquisition of OCL, which occurred in the
fourth quarter of fiscal year 2019, cost of educational services increased 5.4%,
or $6.4 million, in the second quarter and increased 9.3%, or $21.3 million, in
the first six months of fiscal year 2020 compared to the year-ago periods. Cost
increased in the second quarter and first six months of fiscal year 2020 due to
increased housing costs at RUSM's Barbados campus, increased investment in
growth across all reportable segments and increased institutional loan program
bad debt expense of $4.3 million and $7.4 million for the second quarter and
first six months of fiscal year 2020, respectively, primarily at the medical and
veterinary schools. Management evaluates the collectability of receivable
balances monthly and quarterly and bad debt reserves incorporate the most recent
facts and analytics. During the last several quarters management instituted
changes in how the institutional loan portfolio is managed. During the last
quarter, changes in collection efforts have resulted in greater insight as to
the underlying performance of the portfolio. These insights coupled with our
most recent set of circumstances, facts and analytics, resulted in management
increasing the bad debt reserve. Cost increases in the second quarter of fiscal
year 2020 were partially offset by a decrease in costs of $1.3 million
associated with the largest ACAMS conference of the year, which took place in
the first quarter of fiscal year 2020 compared to it taking place in the second
quarter of fiscal year 2019.

As a percentage of revenue, cost of educational services was 47.8% and 49.0% in
the second quarter and first six months of fiscal year 2020, respectively,
compared to 46.5% and 46.8% during the year-ago periods, respectively. The
increases in the percentage were primarily the result of revenue growth in the
lower margin source of RUSM housing and the increase in bad debt expense,
primarily at the medical and veterinary schools.

Student Services and Administrative Expense


The student services and administrative expense category includes expenses
related to sales, student admissions, marketing and advertising, general and
administrative, curriculum development, and amortization expense of finite-lived
intangible assets related to business acquisitions. The following tables present
student services and administrative expense by segment detailing the changes
from the year-ago periods (in thousands):


                                                 Three Months Ended December 31, 2019
                                    Medical and      Financial       Home Office
                                    Healthcare        Services        and Other       Consolidated

Fiscal year 2019 as reported       $      55,964    $     23,425    $      

9,862    $       89,251
Cost increase (reduction)                  4,630           2,082          (5,416)             1,296
Effect of acquisitions                         -           6,101                -             6,101
Fiscal year 2020 as reported       $      60,594    $     31,608    $       4,446    $       96,648

Fiscal year 2020 % change:
Cost increase                                8.3 %           8.9 %             NM               1.5 %
Effect of acquisitions                         -            26.0 %             NM               6.8 %
Fiscal year 2020 % change as
reported                                     8.3 %          34.9 %             NM               8.3 %




                                       44

  Table of Contents


                                                 Six Months Ended December 31, 2019
                                    Medical and      Financial      Home Office
                                    Healthcare       Services        and Other       Consolidated
Fiscal year 2019 as reported       $     111,752    $    48,376    $      18,287    $      178,415
Cost increase (reduction)                 10,962          3,317          (9,215)             5,064
Effect of acquisitions                         -         12,256                -            12,256
Fiscal year 2020 as reported       $     122,714    $    63,949    $       9,072    $      195,735

Fiscal year 2020 % change:
Cost increase                                9.8 %          6.9 %             NM               2.8 %
Effect of acquisitions                         -           25.3 %             NM               6.9 %
Fiscal year 2020 % change as
reported                                     9.8 %         32.2 %             NM               9.7 %


Student services and administrative expense increased 8.3%, or $7.4 million, to
$96.6 million in the second quarter and increased 9.7%, or $17.3 million, to
$195.7 million in the first six months of fiscal year 2020 compared to the
year-ago periods. Excluding the costs added with the acquisition of OCL, which
occurred in the fourth quarter of fiscal year 2019, student services and
administrative expense increased 1.5%, or $1.3 million, in the second quarter
and increased 2.8%, or $5.1 million, in the first six months of fiscal year 2020
compared to the year-ago periods. Cost increases to support future enrollment
growth at Chamberlain, the medical and veterinary schools, ACAMS, and Becker
were the primary drivers of the increase in expense in the second quarter and
first six months of fiscal year 2020. Amortization of finite-lived intangible
assets increased $1.0 million and $1.9 million in the second quarter and first
six months of fiscal year 2020, respectively, compared to the year-ago periods,
driven by OCL intangible asset amortization. In the tables above, approximately
$4.5 and $9.1 million in the second quarter and first six months of fiscal year
2020, respectively, of the cost reduction at home office was driven by
reallocation of costs from Home Office and Other to the segments.

As a percentage of revenue, student services and administrative expense was 36.3% and 37.6% in the second quarter and first six months of fiscal year 2020, respectively, compared to 35.1% and 36.3% during the year-ago periods, respectively. Amortization expense for OCL intangible assets and costs to support enrollment growth caused the increases in this percentage.

Restructuring Expense


Restructuring expense decreased 44.7%, or $1.6 million, to $2.0 million in the
second quarter and decreased 80.3%, or $34.5 million, to $8.5 million in the
first six months of fiscal year 2020 compared to the year-ago periods. The
primary driver of the decreased restructure expense was the result of the
impairment of property and equipment at the Dominica campus of RUSM and
severance related to workforce reductions in Dominica recorded during the fiscal
year 2019 periods. See Note 6 "Restructuring Charges" to the Consolidated
Financial Statements for additional information on restructuring charges.

Additional restructuring expense is expected to be recorded during the remainder of fiscal year 2020 as Adtalem plans to continue to reduce costs.

Gain on Sale of Assets



On September 27, 2019, Adtalem closed on the sale of its Columbus, Ohio, campus
facility. Net proceeds from the sale of $6.4 million resulted in a gain on the
sale of $4.8 million in the first six months of fiscal year 2020. This gain was
recorded at Adtalem's home office, which is classified as "Home Office and
Other" in Note 20 "Segment Information" to the Consolidated Financial
Statements. There was no corresponding gain in the first six months of fiscal
year 2019.

Settlement Gain

In December 2018, AUC and RUSM received the final insurance settlement proceeds
related to the property damage and disruption of operations caused by Hurricanes
Irma and Maria in fiscal year 2018. AUC and RUSM have completed substantially
all planned repairs and replacement of damaged facilities and equipment. AUC and
RUSM received total insurance proceeds of $110.0 million to fully cover the
cumulative expense incurred for the evacuation process, temporary

                                       45

Table of Contents



housing, and transportation of students, faculty and staff, incremental costs of
teaching at alternative sites, and cumulative impairment write-downs. These
costs totaled $106.7 million, less $12.3 million in deductibles, which were
adjusted in the second quarter of fiscal year 2019 from $13.4 million recorded
in the first quarter of fiscal year 2018. The resulting gain of $15.6 million
was recorded in the second quarter of fiscal year 2019. There is no
corresponding gain in the first six months of fiscal year 2020.

Operating Income from Continuing Operations

The following tables present operating income from continuing operations by segment detailing the changes from the year-ago periods (in thousands):




                                          Three Months Ended December 31, 2019
                                Medical and    Financial     Home Office
                                Healthcare      Services      and Other      Consolidated
Fiscal year 2019 as reported   $      60,647   $    9,633   $    (11,611)   $       58,669
Organic change                       (5,921)      (3,212)           5,508          (3,625)
Effect of acquisitions                     -        (742)               -            (742)

Restructuring expense change           2,028      (1,137)             689  

1,580


Settlement gain                     (15,571)            -               -  

(15,571)


Fiscal year 2020 as reported   $      41,183   $    4,542   $     (5,414)   $       40,311





                                            Six Months Ended December 31, 2019
                                 Medical and    Financial     Home Office
                                 Healthcare      Services      and Other      Consolidated

Fiscal year 2019 as reported $ 62,303 $ 14,383 $ (21,249)

 $       55,437
Organic change                       (17,965)      (3,674)           9,446         (12,193)
Effect of acquisitions                      -        (923)               -            (923)

Restructuring expense change           40,916      (3,116)         (3,277) 

34,523


Gain on sale of assets change               -            -           4,779 

4,779


Settlement gain                      (15,571)            -               - 

(15,571)

Fiscal year 2020 as reported $ 69,683 $ 6,670 $ (10,301)

 $       66,052


                                       46

  Table of Contents

The following table presents a reconciliation of operating income from continuing operations (GAAP) to operating income from continuing operations excluding special items (non-GAAP) by segment (in thousands):




                                              Three Months Ended                           Six Months Ended
                                                 December 31,                               December 31,
                                                                Increase                                    Increase
                                      2019          2018       (Decrease)         2019          2018       (Decrease)
Medical and Healthcare:
Operating income (GAAP)             $  41,183    $   60,647        (32.1) %    $   69,683    $   62,303          11.8 %
Restructuring expense                     417         2,445        (82.9) %           544        41,460        (98.7) %
Settlement gain                             -      (15,571)            NM               -      (15,571)            NM
Operating income excluding
special items (non-GAAP)            $  41,600    $   47,521        (12.5) %    $   70,227    $   88,192        (20.4) %

Financial Services:
Operating income (GAAP)             $   4,542    $    9,633        (52.8) %    $    6,670    $   14,383        (53.6) %
Restructuring expense                   1,137             -            NM           3,116             -            NM
Operating income excluding
special items (non-GAAP)            $   5,679    $    9,633        (41.0) %    $    9,786    $   14,383        (32.0) %

Home Office and Other:
Operating loss (GAAP)               $ (5,414)    $ (11,611)          53.4 %    $ (10,301)    $ (21,249)          51.5 %
Restructuring expense                     401         1,090        (63.2) %         4,825         1,548         211.7 %
Gain on sale of assets                      -             -            NM         (4,779)             -            NM
Operating loss excluding special
items (non-GAAP)                    $ (5,013)    $ (10,521)          52.4 %    $ (10,255)    $ (19,701)          47.9 %

Adtalem Global Education:
Operating income (GAAP)             $  40,311    $   58,669        (31.3) %    $   66,052    $   55,437          19.1 %
Restructuring expense                   1,955         3,535        (44.7) %         8,485        43,008        (80.3) %
Gain on sale of assets                      -             -            NM         (4,779)             -            NM
Settlement gain                             -      (15,571)            NM               -      (15,571)            NM
Operating income excluding
special items (non-GAAP)            $  42,266    $   46,633         (9.4) %    $   69,758    $   82,874        (15.8) %


Total consolidated operating income from continuing operations decreased $18.4
million, to $40.3 million in the second quarter and increased $10.6 million, to
$66.1 million in the first six months of fiscal year 2020 compared to the
year-ago periods.

The primary driver of the decreased operating income from continuing operations
in the second quarter of fiscal year 2020 was the $15.6 million hurricane
insurance settlement gain in the second quarter of fiscal year 2019.
Consolidated operating income from continuing operations excluding special items
decreased 9.4%, or $4.4 million, in the second quarter of fiscal year 2020
compared to the year-ago quarter. The primary drivers of this decrease were an
increase in bad debt expense at the medical and veterinary schools of $4.3
million and the loss of operating income at ACAMS due to the timing of their
largest conference of the year taking place in the first quarter of fiscal year
2020 compared to it taking place in the second quarter of fiscal year 2019. In
addition, cost increases to support future enrollment growth at Chamberlain, the
medical and veterinary schools, ACAMS, and Becker were also drivers of the
decrease in operating income in the second quarter of fiscal year 2020.

The primary driver of the increased operating income from continuing operations
in the first six months of fiscal year 2020 was the decrease in restructuring
expense of $34.5 driven by the impairment of property and equipment at the
Dominica campus of RUSM and severance related to workforce reductions in
Dominica recorded during the first six months of fiscal year 2019. This decrease
was partially offset by the $15.6 million hurricane insurance settlement gain
recorded in the first six months of fiscal year 2019. Consolidated operating
income from continuing operations excluding special items decreased 15.8%, or
$13.1 million, in the first six months of fiscal year 2020 compared to the
year-ago period. The primary drivers of this decrease were an increase in bad
debt expense at the medical and veterinary schools of $7.4 million and higher
costs at RUSM of operating in Barbados compared to the post-hurricane temporary
location in Tennessee. In addition, cost increases to support future enrollment
growth at Chamberlain, the medical and veterinary schools, ACAMS, and Becker
were also drivers of the decrease in operating income in the first six months of
fiscal year 2020.



                                       47

  Table of Contents

Medical and Healthcare

Medical and Healthcare segment operating income decreased 32.1%, or $19.5
million, to $41.2 million in the second quarter and increased 11.8%, or $7.4
million, to $69.7 million in the first six months of fiscal year 2020 compared
to the year-ago periods. Segment operating income excluding special items
decreased 12.5%, or $5.9 million, in the second quarter and decreased 20.4%, or
$18.0 million, in the first six months of fiscal year 2020 compared to the
year-ago periods. The primary drivers of the decreases in segment operating
income excluding special items relate to increased marketing expense to drive
future enrollment growth, increased bad debt expense for the institutional loan
programs, primarily at the medical and veterinary schools, higher costs at RUSM
of operating in Barbados compared to the post-hurricane temporary location in
Tennessee, and an increase of approximately $3.7 million in the second quarter
and $7.4 million in the first six months of fiscal year 2020 in home office
costs reallocated from Home Office and Other to the Medical and Healthcare
segment compared to the year-ago periods.

Financial Services



Financial Services segment operating income decreased 52.8%, or $5.1 million, to
$4.5 million in the second quarter and decreased 53.6%, or $7.7 million, to $6.7
million in the first six months of fiscal year 2020 compared to the year-ago
periods. Segment operating income excluding special items decreased 41.0%, or
$4.0 million, in the second quarter and decreased 32.0%, or $4.6 million, in the
first six months of fiscal year 2020 compared to the year-ago periods. Operating
income decreased at Becker and ACAMS driven by increased costs to support future
growth and an operating loss generated by OCL. Operating income in the second
quarter was negatively affected at ACAMS by $4.0 million, due to the timing of
their largest conference of the year taking place in the first quarter of fiscal
year 2020 compared to it taking place in the second quarter of fiscal year 2019.
In addition, approximately $0.8 million in the second quarter and $1.7 million
in the first six months of fiscal year 2020 in home office costs were
reallocated from Home Office and Other to the Financial Services segment
compared to the year-ago periods.

Net Other Expense


Net other expense in the second quarter and first six months of fiscal year 2020
was $31.4 million and $36.1 million, respectively, compared to net other expense
of $5.0 million and $8.9 million in the year-ago periods, respectively. The net
other expense increases were primarily the result of an unrealized $28.0 million
loss on the deal-contingent foreign currency hedge arrangement entered into in
connection with the announced proposed sale of Adtalem Brazil (as discussed in
Note 4 "Discontinued Operations and Assets Held for Sale" to the Consolidated
Financial Statements) to economically hedge the Brazilian Real denominated
purchase price through mitigation of the currency exchange rate risk. The hedge
agreement has a total notional amount of R$2,154 million (approximately $536
million as of December 31, 2019). Fees associated with this arrangement are
payable upon closing of the sale, only if the sale closes, and will vary based
on the closing date, based on a pre-defined schedule in the hedge agreement. The
derivative associated with the hedge agreement does not qualify for hedge
accounting treatment under Accounting Standards Codification ("ASC") 815, and as
a result, all changes in fair value are recorded within the income statement.
The change in value in this hedge does not result in a change in proceeds, net
of the hedge settlement, from the amount originally expected from the sale
transaction.

Income Taxes


Our effective income tax rate ("ETR") from continuing operations can differ from
the 21% U.S. federal statutory rate due to several factors, including the rate
of tax applied to earnings outside the U.S., tax incentives, changes in
valuation allowances, liabilities for uncertain tax positions, and tax benefits
on stock compensation awards. Additionally, our ETR may be impacted by the
provisions from the Tax Cuts and Jobs Act of 2017 (the "Tax Act"), which include
primarily a tax on global intangible low-taxed income ("GILTI"), a deduction for
foreign derived intangible income ("FDII"), and a limitation of tax benefits on
certain executive compensation. The impact of the Tax Act may be revised in
future periods as we obtain additional data and any new regulations or guidance
that may be released.

The ETR from continuing operations for the three months ended December 31, 2019
was 85.3%, an increase from 22.1% for the three months ended December 31, 2018.
This increase is primarily due to the inability to record a tax benefit on a
pre-tax unrealized loss of $28.0 million from a derivative contract related to
the deal-contingent hedge agreement on the pending Adtalem Brazil sale (see Note
4 "Discontinued Operations and Assets Held for Sale" for additional

                                       48

Table of Contents



information). Also contributing to the increase were a reduction in the
percentage of earnings from foreign operations, which are taxed at rates lower
than those applied to domestic earnings, and a reduction in tax benefits for
stock-based compensation, offset by various impacts due to the sale of DeVry
University in the comparable period. Excluding the one-time effects of the
derivative contract and sale of DeVry University (a non-GAAP financial measure),
the ETR from continuing operations for the three months ended December 31, 2019
and December 31, 2018, was 20.5% and 19.2%, respectively.

The ETR for the six months ended December 31, 2019 was 37.6%, an increase from
20.5% for the six months ended December 31, 2018. This increase is primarily due
to the derivative contract related to the deal-contingent hedge agreement on the
pending Adtalem Brazil sale, a decrease in the percentage of earnings from
foreign operations versus the comparable period, and an increased net charge
associated with the impact of GILTI & FDII. Excluding the one-time effects of
the derivative contract and sale of DeVry University (a non-GAAP financial
measure), the ETR from continuing operations for the six months ended December
31, 2019 and December 31, 2018, was 19.4% and 17.2%, respectively.

Discontinued Operations



Income (loss) from discontinued operations includes $7.6 million in the second
quarter and $13.6 million in the first six months of fiscal year 2020,
respectively, in costs primarily consisting of ongoing litigation costs,
settlements, and other divestiture costs related to the DeVry University,
Carrington, and Adtalem Brazil divestitures. See Note 4 "Discontinued Operations
and Assets Held for Sale" to the Consolidated Financial Statements for
additional information.

Beginning in the second quarter of fiscal year 2018, DeVry University operations
were classified as discontinued operations. In addition, beginning in the fourth
quarter of fiscal year 2018, Carrington operations were classified as
discontinued operations. See Note 2 "Discontinued Operations" to the
Consolidated Financial Statements in Item 8 of Adtalem's Annual Report on Form
10-K for the fiscal year ended June 30, 2019 ("2019 Form 10-K") for additional
information. The divestiture of both of these operations was completed in the
second quarter of fiscal year 2019. As a result, management discontinued
discussion of the DeVry University and Carrington operating results beginning
with the second quarter of fiscal year 2019 Quarterly Report on Form 10-Q as
comparable results are no longer meaningful. Management will continue to
disclose and discuss Adtalem Brazil operations in its public filings until the
period in which the sale closes as Adtalem Brazil operations continue to have an
effect on Adtalem's reported net income.

Adtalem Brazil

The following table presents revenue for Adtalem Brazil detailing the changes from the year-ago periods (in thousands):




                                                 Three Months Ended           Six Months Ended
                                                  December 31, 2019           December 31, 2019

Fiscal year 2019 as reported                    $              62,633      

$             109,884
Organic growth                                                (2,990)                     (4,010)
Effect of currency change                                     (4,490)                     (5,069)

Fiscal year 2020 as reported                    $              55,153       $             100,805

Fiscal year 2020 % change:
Organic growth (constant currency, non-GAAP)                    (4.8) %                     (3.6) %
Effect of currency change                                       (7.2) %                     (4.6) %
Fiscal year 2020 % change as reported                          (11.9) %                     (8.3) %


Revenue at Adtalem Brazil decreased 11.9%, or $7.5 million, to $55.2 million in
the second quarter and decreased 8.3%, or $9.1 million, to $100.8 million in the
first six months of fiscal year 2020 compared to the year-ago periods. The
decrease in value of the Brazilian Real compared to the U.S. dollar decreased
reported revenue in the second quarter and first six months of fiscal year 2020
by $4.5 million and $5.1 million, respectively, compared to the year-ago
periods. Constant currency calculations assume conversions of local currency
amounts at exchange rates in effect in the year-ago period compared to those
conversions at exchange rates in effect during the current fiscal year period.
On a constant currency basis (a non-GAAP financial measure), revenue decreased
4.8% in the second quarter and decreased 3.6% in the first six months of fiscal
year 2020 compared to the year-ago periods. Declines in enrollment at Wyden

Educational

                                       49

  Table of Contents

institutions ("Wyden") and in law exam test preparation courses, along with increased discounting were the primary drivers of the revenue decreases.

Brazil's economy presented challenges for enrollment growth and created pricing
pressures in the education sector. Adtalem Brazil's revenue results have been
negatively impacted by these conditions as well as reductions in Brazil's
government-funded loan program, "Fundo de Financiamento Estudantil" or "Students
Financing Fund" ("FIES") and increased competition. Adtalem Brazil students are
eligible for loans under the FIES program, which is financed by the Brazilian
government. The Brazilian government has stated that it is supportive of the
FIES program, which is an important factor in helping to increase the number of
college graduates. However, the changes enacted during fiscal year 2018 reducing
the number of contracts available for grant under the FIES program by
approximately 31% to all higher education institutions in Brazil, have impacted
Adtalem Brazil's growth. Adtalem Brazil institutions have increased efforts to
attract more non-FIES program students in order to diversify their payer mix.
Also, Adtalem Brazil is working with private lenders to increase funding sources
for prospective students. Management believes Adtalem Brazil institutions offer
programs of study and operate in areas of the country that the Brazilian
government favors in issuing loans under the FIES program. Should economic
conditions continue to weaken and additional austerity measures be instituted by
the Brazilian government, Adtalem Brazil's ability to grow its student
enrollment may be further impacted.

Adtalem Brazil Student Enrollment:




                            Fiscal Year 2020       Fiscal Year 2019
Term                           Sept. 2019       Sept. 2018    Mar. 2019
New students                          17,588        17,956       27,505
% change from prior year               (2.0) %        23.8 %       17.7 %
Total students                        76,904        81,088       79,919
% change from prior year               (5.2) %         3.5 %        5.6 %


These enrollment figures include students enrolled in degree-granting programs
and exclude students enrolled in test preparation programs at Damásio
Educacional ("Damasio"). The decrease in enrollment in the September 2019 term
is driven by a decline in new and continuing onsite enrollment at Wyden and the
degree granting operations of Damasio, partially offset with increases in new
and continuing online enrollment and enrollment increases at Grupo Ibmec
Educacional S.A. ("Ibmec"). Enrollment increases in online students are less
beneficial to revenue growth due to lower tuition pricing of the online
programs.

The following table presents operating income for Adtalem Brazil detailing the changes from the year-ago periods (in thousands):




                                                Three Months Ended        Six Months Ended
                                                December 31, 2019         December 31, 2019
Fiscal year 2019 as reported                  $               11,630    $              12,354
Organic change                                                   533                    3,407
Restructuring expense change                                   (282)                    (241)
Effect of currency change                                      (983)                  (1,311)
Fiscal year 2020 as reported                  $               10,898    $              14,209


Adtalem Brazil operating income decreased $0.7 million to $10.9 million in the
second quarter and increased $1.9 million to $14.2 million in the first six
months of fiscal year 2020 compared to the year-ago periods. Operating income
was reduced by the effect of exchange rate changes by $1.0 million in the second
quarter and $1.3 million in the first six months of fiscal year 2020. On a
constant currency basis and excluding the effect of restructuring charges (a
non-GAAP financial measure), Adtalem Brazil operating income increased $0.5
million in the second quarter and increased $3.4 million in the first six months
of fiscal year 2020 compared to the year-ago periods, primarily driven by cost
reduction measures implemented to offset declining enrollment and the need for
higher discounting. These operating income amounts in fiscal years 2020 and 2019
have been adjusted for the reduction in home office expenses allocated to
Adtalem Brazil within discontinued operations and now allocated to continuing
operations. For fiscal year 2020, home office costs to support the remaining
businesses are being allocated to the Medical and Healthcare and Financial

Services segments.

                                       50

  Table of Contents

For fiscal year 2019, these costs were allocated to Home Office and Other. See Note 20 "Segment Information" to the Consolidated Financial Statements for additional information.



Regulatory Environment

Student Payments

Adtalem's primary source of liquidity is the cash received from payments for
student tuition, books, other educational materials, and fees. These payments
include funds originating as financial aid from various federal and state loan
and grant programs, student and family educational loans ("private loans"),
employer educational reimbursements, scholarships, and student and family
financial resources. Adtalem continues to provide financing options for its
students, including Adtalem's institutional loan programs.

The following table, which excludes DeVry University, Carrington, and Adtalem
Brazil revenue, summarizes Adtalem's revenue by fund source as a percentage of
total revenue for fiscal years 2019 and 2018:


                                                                  Fiscal Year
Funding source:                                                  2019      2018
Federal assistance (Title IV) program funding (grants and
loans)                                                              59 %      59 %
Private loans                                                        2 %   

2 % Student accounts, cash payments, private scholarships, employer and military provided tuition assistance, and other 39 %


  39 %
Total                                                              100 %     100 %

The pattern of cash receipts during the year is seasonal. Adtalem's cash collections on accounts receivable peak at the start of each institution's term. Accounts receivable reach their lowest level at the end of each term.

Financial Aid


Like other higher education institutions, Adtalem is highly dependent upon the
timely receipt of federal financial aid funds. All financial aid and assistance
programs are subject to political and governmental budgetary considerations. In
the U.S., the Higher Education Act ("HEA") guides the federal government's
support of postsecondary education. If there are changes to financial aid
programs that restrict student eligibility or reduce funding levels, Adtalem's
financial condition and cash flows could be materially and adversely affected.
See Item 1A "Risk Factors" in our 2019 Form 10-K for a discussion of student
financial aid related risks.

In addition, government-funded financial assistance programs are governed by
extensive and complex regulations in the U.S. Like any other educational
institution, Adtalem's administration of these programs is periodically reviewed
by various regulatory agencies and is subject to audit or investigation by other
governmental authorities. Any violation could be the basis for penalties or
other disciplinary action, including initiation of a suspension, limitation, or
termination proceeding.

If the U.S. Department of Education ("ED") determines that we have failed to
demonstrate either financial responsibility or administrative capability in any
pending program review, or otherwise determines that an institution has violated
the terms of its Program Participation Agreement ("PPA"), we could be subject to
sanctions including: fines, penalties, reimbursement for discharged loan
obligations, a requirement to post a letter of credit, and/or suspension or
termination of our eligibility to participate in the Title IV programs.

On October 13, 2016, DeVry University and ED reached a negotiated agreement (the
"ED Settlement") to settle the claims asserted in a Notice of Intent to Limit
from the Multi-Regional and Foreign School Participation Division of the Federal
Student Aid office of the Department of Education ("ED FSA"). Under the terms of
the ED Settlement, among other things, without admitting wrongdoing, DeVry
University agreed to certain compliance requirements regarding its past and
future advertising, that DeVry University's participation in Title IV programs
is subject to provisional certification for five years and that DeVry University
is required to post a letter of credit equal to the greater of 10% of DeVry
University's annual Title IV disbursements or $68.4 million for a five-year
period. The posted letter of credit continues to

                                       51

Table of Contents


be posted by Adtalem following the closing of the sale of DeVry University and
reduces Adtalem's borrowing capacity dollar-for-dollar under its Credit Facility
(as defined in Note 13 "Debt" to the Consolidated Financial Statements).

An ED regulation known as the "90/10 Rule" affects only proprietary
postsecondary institutions, such as Chamberlain, AUC, RUSM, and RUSVM. Under
this regulation, an institution that derives more than 90% of its revenue on a
cash basis from Title IV student financial assistance programs in two
consecutive fiscal years loses eligibility to participate in these programs for
at least two fiscal years. The following table details the percentage of revenue
on a cash basis from federal financial assistance programs (excluding the U.S.
Department of Veterans Affairs and military tuition assistance benefits) for
each of Adtalem's Title IV-eligible institutions for fiscal years 2019 and

2018:


                                                            Fiscal Year
                                                           2019     2018
Chamberlain University                                        62 %    62 %

American University of the Caribbean School of Medicine 75 % 74 % Ross University School of Medicine

                            83 %    81 %
Ross University School of Veterinary Medicine                 83 %    82 %


In September 2016, Adtalem committed to voluntarily limit to 85% the amount of
revenue that each of its four Title IV-eligible institutions derive from federal
funding, including the U.S. Department of Veterans Affairs and military tuition
assistance benefits. As disclosed in the third party review reports that have
been made publicly available, Adtalem's institutions have met this lower
threshold for each fiscal year since the commitment was made. Adtalem is
committed to implementing measures to promote responsible recruitment and
enrollment, successful student outcomes, and informed student choice. Management
believes students deserve greater transparency to make informed choices about
their education. This commitment builds upon a solid foundation and brings
Adtalem to a new self-imposed level of public accountability and transparency.

A financial responsibility test is required for continued participation by an
institution's students in U.S. federal financial assistance programs. For
Adtalem's participating institutions, this test is calculated at the
consolidated Adtalem level. The test is based upon a composite score of three
ratios: an equity ratio that measures the institution's capital resources; a
primary reserve ratio that measures an institution's ability to fund its
operations from current resources; and a net income ratio that measures an
institution's ability to operate profitably. A minimum score of 1.5 is necessary
to meet ED's financial standards. Institutions with scores of less than 1.5 but
greater than or equal to 1.0 are considered financially responsible, but require
additional oversight. These schools are subject to heightened cash monitoring
and other participation requirements. An institution with a score of less than
1.0 is considered not financially responsible. However, a school with a score of
less than 1.0 may continue to participate in the Title IV programs under
provisional certification. In addition, this lower score typically requires that
the school be subject to heightened cash monitoring requirements and post a
letter of credit (equal to a minimum of 10% of the Title IV aid it received in
the institution's most recent fiscal year).

For the past several years, Adtalem's composite score has exceeded the required
minimum of 1.5. If Adtalem becomes unable to meet requisite financial
responsibility standards or otherwise demonstrate, within the regulations, its
ability to continue to provide educational services, then Adtalem could be
subject to heightened cash monitoring or be required to post a letter of credit
to enable its students to continue to participate in federal financial
assistance programs.

Liquidity and Capital Resources


Adtalem's consolidated cash and cash equivalents balance of $67.3 million,
$204.2 million, and $208.3 million as of December 31, 2019, June 30, 2019, and
December 31, 2018, respectively, included cash and cash equivalents held at
Adtalem's international operations of $37.8 million, $75.3 million, and $30.0
million as of December 31, 2019, June 30, 2019, and December 31, 2018,
respectively, which is available to Adtalem for general company purposes. As of
December 31, 2019, the cash and cash equivalents balance attributable to Adtalem
Brazil was $104.0 million, which is excluded from the December 31, 2019 balances
above as they are classified as assets held for sale and are not available for
Adtalem general company purposes. In accordance with the terms of the Adtalem
Brazil purchase agreement (see Note 4 "Discontinued Operations and Assets Held
for Sale" to the Consolidated Financial Statements), Adtalem expects to receive
approximately $74 million in settlement of cash balances at Adtalem Brazil as of
June 30, 2019 of $89 million, net of indebtedness of $15 million

                                       52

Table of Contents



Under the terms of Adtalem institutions' participation in financial aid
programs, certain cash received from state governments and ED is maintained in
restricted bank accounts. Adtalem receives these funds either after the
financial aid authorization and disbursement process for the benefit of the
student is completed, or just prior to that authorization. Once the
authorization and disbursement process for a particular student is completed,
the funds may be transferred to unrestricted accounts and become available for
Adtalem to use in operations. This process generally occurs during the academic
term for which such funds have been authorized. Cash in the amount of $3.5
million, $1.0 million, and $0.8 million was held in restricted bank accounts as
of December 31, 2019, June 30, 2019, and December 31, 2018, respectively.

Cash Flow Summary

Operating Activities



The following table provides a summary of cash flows from operations (in
thousands):


                                                                Six Months Ended
                                                                 December 31,
                                                              2019           2018

Income from continuing operations                          $    18,711    $

37,006


Non-cash items                                                  90,425     

78,349


Changes in assets and liabilities                            (133,432)     

(113,291)


Net cash (used in) provided by operating
activities-continuing operations                           $  (24,296)    $

2,064

Cash used in operating activities by continuing operations in the first six months of fiscal year 2020 was $24.3 million compared to cash provided by operating activities of $2.1 million in the year-ago period. Net income from continuing operations decreased by $18.3 million in the first six months of fiscal year 2020 compared to the year-ago period.

The increase in non-cash items of $12.1 million in the first six months of fiscal year 2020 compared to the year-ago period was primarily driven by the following:

A decrease of $37.5 million in depreciation and write-offs of property and

? equipment. This was primarily the result of recording $40.1 million in

impairment write-downs of property and equipment at RUSM's Dominica campus in

the first six months of fiscal year 2019.

? An increase of $21.3 million in amortization and adjustments to operating lease

assets which results from the implementation of ASC 842 on July 1, 2019.

? A decrease of $20.8 million in the deferred income tax provision related to the

timing of deductions.

An increase of $26.4 million in the unrealized loss on investments and

derivative contracts driven by an unrealized loss on the deal-contingent

? foreign currency hedge arrangement entered into in the second quarter of fiscal

year 2020 to economically hedge the Brazilian Real denominated sales price of


   Adtalem Brazil through mitigation of the currency exchange rate risk.

A decrease of $15.6 million in insurance settlement gain, which was recorded in

? fiscal year 2019 resulting from final settlement of hurricane claims which were

in excess of expense recorded for hurricane related costs.

? An increase of $8.8 million in provision for bad debts due to increases in

reserves for institutional student loans.

? An increase in realized gain on the sale of assets of $4.8 million from the

sale of the Columbus, Ohio, campus facility.

Changes in assets and liabilities from June 30, 2019 reduced operating cash flow by $133.4 million, driven by the following:

A $14.8 million decrease resulting from an increase in accounts receivable

balances (excluding provisions for bad debts) due to higher accounts receivable

balances at the Medical and Healthcare and Financial Services segments. These

balances are seasonally higher at December 31, 2019 at AUC, RUSM, and RUSVM

? compared to June 30, 2019 due to the timing of clinical billings and higher

basic science enrollment in the fall semester. The increase in accounts

receivable at the Financial Services segment is driven by an increase in


   accounting firm receivables at Becker due to higher firm revenue compared to
   the year-ago period.


                                       53
  Table of Contents

A $44.5 million decrease resulting from a decrease in deferred revenue balances

? due to the timing of the AUC, RUSM, and RUSVM academic terms at December 31,

2019, which is the end of a term, compared to June 30, 2019, which is in the

middle of a term.

A $27.5 million decrease in operating lease liabilities which results from the

? payments under operating lease liabilities recorded upon the implementation of

ASC 842 on July 1, 2019.

A $48.8 million decrease resulting from a change in prepaid expense and other

? current assets, accounts payable, accrued payroll and benefits, and accrued

liabilities balances due to the timing of disbursements in the normal


   processing cycles.


Investing Activities

Capital expenditures in the first six months of fiscal year 2020 were $20.3 million compared to $32.1 million in the year-ago period. The capital expenditures in fiscal year 2020 include spending for Chamberlain new campus development, maintenance, and Adtalem's home office reorganization.



Capital spending for the remainder of fiscal year 2020 will support continued
investment for new campus development at Chamberlain and maintenance at the
medical and veterinary schools. Management anticipates full fiscal year 2020
capital spending to be in the $45 to $50 million range, including $20.3 million
spent during the first six months of fiscal year 2020. The source of funds for
this capital spending will be from operations or the Credit Facility (as defined
and discussed in Note 13 "Debt" to the Consolidated Financial Statements).

On September 27, 2019, Adtalem closed on the sale of its Columbus, Ohio, campus
facility. Net proceeds from the sale of $6.4 million resulted in a gain on the
sale of $4.8 million. This gain was recorded at Adtalem's home office, which is
classified as "Home Office and Other" in Note 20 "Segment Information" to the
Consolidated Financial Statements.

In the second quarter of fiscal year 2019, AUC and RUSM received the final
insurance proceeds in settlement of claims made related to Hurricanes Irma and
Maria. The total proceeds received from insurance settlements were in excess of
expense recorded for hurricane-related evacuation processes, temporary housing,
and transportation of students, faculty and staff, and incremental costs of
teaching at alternative sites, less deductibles. The resulting excess proceeds
of $35.7 million were applied against asset damages and capital repairs and
replacement in the second quarter of fiscal year 2019, which requires
classification of the gain as an investing activity.

On December 4, 2018, Adtalem completed the sale of its ownership of all the
outstanding equity interests in U.S. Education Holdings LLC, the holding company
of Carrington, to San Joaquin Valley College, Inc. ("SJVC"), pursuant to terms
and conditions of the Membership Interest Purchase Agreement ("MIPA"), dated
June 28, 2018. The equity interests were sold for de minimis consideration,
subject to customary adjustments for working capital and required transfer of
$9.9 million of cash and restricted cash balances in the second quarter fiscal
year 2019.

On December 11, 2018, Adtalem completed the sale of the equity interest of DeVry
University to Cogswell Education, LLC ("Cogswell") under the terms of the
purchase agreement dated December 4, 2017. The equity interests were sold for de
minimis consideration, subject to customary adjustments for working capital and
required $39.0 million of cash and restricted cash balances in the second
quarter of fiscal year 2019. In connection with the completion of the sale,
Adtalem loaned $10.0 million to DeVry University under the terms of the
promissory note, dated December 11, 2018 (the "Note"). The Note bears interest
at a rate of 4% per annum, payable annually in arrears, and has a maturity

date
of January 1, 2022.

                                       54

  Table of Contents

Financing Activities

The following table provides a summary of cash flows from financing activities
(in thousands):


                                                             Six Months Ended
                                                              December 31,
                                                           2019           2018

Proceeds from exercise of stock options                 $     2,028    $   

16,784


Repurchase of common stock for treasury                   (100,019)      

(115,933)


Net borrowings (payments) under credit facility              13,500       

(1,500)


Payment for purchase of redeemable noncontrolling
interest of subsidiary                                      (6,247)        

-


Other                                                          (32)       

(6,089)


Net cash used in financing activities-continuing
operations                                              $  (90,770)    $ 

(106,738)




As of December 31, 2019, the amount available under the current share repurchase
program, announced on November 7, 2018, totaled $82.1 million. On January 31,
2020, the Board of Directors (the "Board") authorized Adtalem's twelfth share
repurchase program, which allows Adtalem to repurchase up to $300 million of its
common stock through December 31, 2021. The new program will commence when the
repurchases from the current program are complete. See Note 15 "Share
Repurchases" to the Consolidated Financial Statements for additional information
on our current share repurchase program.

As of December 31, 2019, the amount of debt outstanding under our credit facility was $420.5 million. See Note 13 "Debt" to the Consolidated Financial Statements for additional information on our credit agreement.



Management believes current balances of unrestricted cash, cash generated from
operations, and our credit facility will be sufficient to fund both Adtalem's
current domestic and international operations, growth plans, and current share
repurchase program for the foreseeable future unless significant investment
opportunities should arise.

Contractual Arrangements



Adtalem's long-term contractual obligations consist of its $600 million Credit
Facility (as defined and discussed in Note 13 "Debt" to the Consolidated
Financial Statements), operating leases (discussed in Note 11 "Leases" to the
Consolidated Financial Statements) on facilities, and agreements for various
services.

In fiscal year 2018, Adtalem recorded a liability of $96.3 million for the
one-time transition tax on the deemed repatriation of foreign earnings, pursuant
to the Tax Act. This amount was reduced to $8.7 million after utilization of tax
credits and current and prior year tax losses, and is payable over eight years.
The first installment will be required in fiscal year 2021.

On December 11, 2018, Adtalem completed the sale of DeVry University to
Cogswell. In connection with the closing of the sale, Adtalem loaned to DeVry
University $10.0 million under the terms of the promissory note, dated as of
December 11, 2018. The Note bears interest at a rate of 4% per annum, payable
annually in arrears, and has a maturity date of January 1, 2022. DeVry
University may make prepayments on the Note.

On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul
College Prep Foundation ("DePaul College Prep") for $52.0 million. Adtalem
received $5.2 million of cash at the time of closing and holds a mortgage,
secured by the property, from DePaul College Prep for $46.8 million. The
mortgage is due on July 31, 2024 as a balloon payment and bears interest at a
rate of 4% per annum, payable monthly. The buyer has an option to make
prepayments.

Adtalem is leasing space to DeVry University at four facilities owned by Adtalem
and subleasing space, in full or in part, at an additional 24 facilities, of
which 16 are subleased to DeVry University and/or Carrington. Adtalem remains
the primary lessee on the 24 underlying leases. These lease and sublease
agreements were entered into at comparable market rates and the terms range from
one to six years. Future minimum lease and sublease rental income under these
agreements as of December 31, 2019, were as follows (in thousands):

                                       55

  Table of Contents


Fiscal Year                                Amount
2020 (remaining)                          $ 12,131
2021                                        19,859
2022                                        16,935
2023                                        16,195
2024                                        10,434
Thereafter                                   7,307

Total lease and sublease rental income $ 82,861

Adtalem also assigned certain leases to DeVry University and Carrington but remains contingently liable under these leases.

Seasonality


The seasonal pattern of Adtalem's enrollments and its educational programs'
starting dates affect the results of operations and the timing of cash flows.
Therefore, management believes that comparisons of its results of operations
should primarily be made to the corresponding period in the preceding year.
Comparisons of financial position should be made to both the end of the previous
fiscal year and to the end of the corresponding quarterly period in the
preceding year.

Off-Balance Sheet Arrangements



Adtalem is not a party to any off-balance sheet financing or contingent payment
arrangements, nor are there any unconsolidated subsidiaries. Adtalem has not
extended any loans to any officer, director, or other affiliated person. Adtalem
has not entered into any synthetic leases, and there are no residual purchase or
value commitments related to any facility lease. In connection with the
announced proposed sale of Adtalem Brazil, Adtalem entered into a
deal-contingent foreign currency hedge arrangement to economically hedge the
Brazilian Real denominated sales price through mitigation of the currency
exchange rate risk. The hedge agreement has a total notional amount of R$2,154
million (approximately $536 million as of December 31, 2019). Fees associated
with this arrangement are payable upon closing of the sale, only if the sale
closes, and will vary based on the closing date, based on a pre-defined schedule
in the hedge agreement. The derivative associated with the hedge agreement does
not qualify for hedge accounting treatment under ASC 815, and as a result, all
changes in fair value are recorded within the income statement. Adtalem recorded
a pre-tax unrealized loss on the hedge agreement derivative based on the foreign
exchange forward spot rate as of December 31, 2019 of $28.0 million in the
second quarter of fiscal year 2020. The change in value in this hedge does not
result in a change in proceeds, net of the hedge settlement, from the amount
originally expected from the sale transaction. Adtalem did not enter into any
other derivatives, swaps, futures contracts, calls, hedges, or non-exchange
traded contracts during the first six months of fiscal year 2020.

Critical Accounting Policies and Estimates

There have been no material changes in our critical accounting policies and estimates as disclosed in our 2019 Form 10-K.

Recent Accounting Pronouncements

For a discussion of recent accounting pronouncements, see Note 2 "Summary of Significant Accounting Policies" to the Consolidated Financial Statements.

Forward-Looking Statements



Certain statements in this Quarterly Report on Form 10-Q are forward-looking
statements as defined in the Private Securities Litigation Reform Act of 1995.
Forward-looking statements provide current expectations of future events based
on certain assumptions and include any statement that does not directly relate
to any historical or current fact. Forward-looking statements can also be
identified by words such as "future," "believe," "expect," "anticipate,"
"estimate," "plan," "intend," "may," "will," "would," "could," "can,"
"continue," "preliminary," "range," and similar terms. These forward-looking
statements are subject to risk and uncertainties that could cause actual results
to differ materially from those

                                       56

Table of Contents


described in the statements. These risk and uncertainties include the risk
factors described in Item 1A "Risk Factors" of our 2019 Form 10-K and this
Quarterly Report on Form 10-Q, which should be read in conjunction with the
forward-looking statements in this Quarterly Report on Form 10-Q. These
forward-looking statements are based on information available to us as of the
date any such statements are made, and we do not undertake any obligation to
update any forward-looking statement, except as required by law.

Non-GAAP Financial Measures and Reconciliations


We believe that certain non-GAAP financial measures provides investors with
useful supplemental information regarding the underlying business trends and
performance of Adtalem's ongoing operations and is useful for period-over-period
comparisons. We use these supplemental non-GAAP financial measures internally in
our assessment of performance and budgeting process. However, these non-GAAP
financial measures should be not be considered as a substitute for, or superior
to, measures of financial performance prepared in accordance with GAAP. The
following are non-GAAP financial measures used in this Quarterly Report on Form
10-Q:

Net income from continuing operations attributable to Adtalem excluding special items (most comparable GAAP measure: net income attributable to Adtalem) - Measure of Adtalem's net income attributable to Adtalem adjusted for restructuring expense, gain on sale of assets, settlement gain, tax charges related to the divestiture of DeVry University, loss on derivative, and discontinued operations.


Earnings per share from continuing operations excluding special items (most
comparable GAAP measure: earnings per share) - Measure of Adtalem's diluted
earnings per share adjusted for restructuring expense, gain on sale of assets,
settlement gain, tax charges related to the divestiture of DeVry University,
loss on derivative, and discontinued operations.

Operating income from continuing operations excluding special items (most
comparable GAAP measure: operating income from continuing operations) - Measure
of Adtalem's operating income from continuing operations adjusted for
restructuring expense, gain on sale of assets, and settlement gain. This measure
is applied on a consolidated and segment basis, depending on the context of the
discussion.

Effective income tax rate from continuing operations excluding special items
(most comparable GAAP measure: effective income tax rate from continuing
operations) - Measure of Adtalem's effective tax rate adjusted for tax effect on
loss on derivative and tax charges related to the divestiture of DeVry
University.

A description of special items in our non-GAAP financial measures described above are as follows:

Restructuring charges primarily related to the sale of Becker's courses for

? healthcare students, real estate consolidations at Adtalem's home office, and

the closing of the RUSM campus in Dominica.

? Gain on the sale of Adtalem's Columbus, Ohio, campus facility.

? Settlement gain related to the final insurance settlement related to Hurricanes

Irma and Maria at AUC and RUSM.

Loss on the deal-contingent foreign currency hedge arrangement entered into in

? connection with the announced proposed sale of Adtalem Brazil to economically

hedge the Brazilian Real denominated purchase price through mitigation of the

currency exchange rate risk.

? Tax charges related to the divestiture of DeVry University.

? Discontinued operations include the operations of Adtalem Brazil, Carrington,


   and DeVry University.




Constant currency - Certain information for Adtalem Brazil, which is classified
as a discontinued operation, is presented on a constant currency basis, which is
a non-GAAP measure, along with the nearest GAAP measure.

The following tables provide a reconciliation from the most directly comparable
GAAP measure to these non-GAAP financial measures. The operating income
reconciliation is included in the results of operations section above and the
constant currency disclosures are located within the Adtalem Brazil results of
operations discussion above.

                                       57

Table of Contents

Net income attributable to Adtalem reconciliation to net income from continuing operations attributable to Adtalem excluding special items (in thousands):




                                               Three Months Ended          Six Months Ended
                                                  December 31,               December 31,
                                               2019          2018         2019          2018

Net income attributable to Adtalem (GAAP)    $   5,525    $   17,295    $ 

19,886    $    7,765
Restructuring expense                            1,955         3,535        8,485        43,008
Gain on sale of assets                               -             -      (4,779)             -
Settlement gain                                      -      (15,571)            -      (15,571)
Loss on derivative                              28,006             -       28,006             -
Tax charges related to the divestiture of
DeVry University                                     -         1,526            -         1,526
Income tax impact on non-GAAP adjustments
(1)                                              (461)         2,829        (804)       (5,123)
Loss from discontinued operations              (4,117)        24,650        (961)        29,393
Net income from continuing operations
attributable to Adtalem excluding special
items (non-GAAP)                             $  30,908    $   34,264    $ 

49,833 $ 60,998

(1) Represents the income tax impact of non-GAAP continuing operations

adjustments that is recognized in our GAAP financial statements.

Earnings per share reconciliation to earnings per share from continuing operations excluding special items (shares in thousands):




                                               Three Months Ended        Six Months Ended
                                                 December 31,             December 31,
                                                2019         2018        2019        2018

Earnings per share, diluted (GAAP)           $     0.10    $   0.29    $   0.36    $   0.13
Effect on diluted earnings per share:
Restructuring expense                              0.04        0.06        0.15        0.71
Gain on sale of assets                                -           -      (0.09)           -
Settlement gain                                       -      (0.26)           -      (0.26)
Loss on derivative                                 0.52           -        0.51           -
Tax charges related to the divestiture of
DeVry University                                      -        0.03           -        0.03
Income tax impact on non-GAAP adjustments
(1)                                              (0.01)        0.05      (0.01)      (0.08)
Loss from discontinued operations                (0.08)        0.41      (0.02)        0.49
Earnings per share from continuing
operations excluding special items,
diluted (non-GAAP)                           $     0.57    $   0.57    $   0.90    $   1.01
Diluted shares used in EPS calculation           54,280      60,000      

55,192 60,598

(1) Represents the income tax impact of non-GAAP continuing operations


    adjustments that is recognized in our GAAP financial statements.


                                       58

  Table of Contents

Effective income tax rate from continuing operations reconciliation to effective
income tax rate from continuing operations excluding special items (in
thousands):


                                                                  Three Months Ended          Six Months Ended
                                                                     December 31,               December 31,
                                                                  2019          2018          2019         2018
Pre-tax results:

Income from continuing operations before income taxes (GAAP)    $   8,873    $   53,714    $   29,987    $  46,533
Loss on derivative                                                 28,006             -        28,006            -

Income from continuing operations before income taxes excluding special items (non-GAAP)

$  36,879    $   53,714    $   57,993    $  46,533

Taxes:
Income tax provision (GAAP)                                     $ (7,570)    $ (11,857)    $ (11,276)    $ (9,527)

Tax charges related to the divestiture of DeVry University              -         1,526             -        1,526

Income tax provision excluding special items (non-GAAP) $ (7,570)

$ (10,331) $ (11,276) $ (8,001)



Tax rate:
Effective income tax rate (GAAP)                                     85.3 %        22.1 %        37.6 %       20.5 %
Effective income tax rate excluding special items (non-GAAP)         20.5 %

19.2 % 19.4 % 17.2 %

© Edgar Online, source Glimpses